Maine cancels low-cost Canadian drug program
AUGUSTA, Maine—Maine officials' ruling that CanaRx, a Canadian firm that distributes prescription medications by mail, cannot be licensed in Maine will affect 1,200 Maine households using the company's services.
The Bangor Daily News (bit.ly/NgREjj) says Attorney General William Schneider's decision imperils more than $3 million in annual savings budgeted for the state employees' health plan.
CanaRx senior program adviser Chris Collins says the decision affects about 1,200 Maine households and also poses financial repercussions for the city of Portland and Guilford-based Hardwood Products Co., both of which have contracted with CanaRx for years.
CanaRx offers reduced prices to plan providers and does not charge co-payments to participants, creating significant savings for both.
Information from: Bangor Daily News, http://www.bangordailynews.com